POLD1 and ovarian carcinoma: Furthermore, using cisplatin-resistant and cisplatin-sensitive ovarian cancer cell lines, Xing et al. demonstrated that POLD1 was highly expressed in the platinum-sensitive group, whereas chemoresistant cell lines possessed a reduced expression of POLD1 [93].